Diffuse large B cell lymphoma (DLBCL): bilateral vanishing tibiae

Ann Hematol. 2018 Aug;97(8):1497-1500. doi: 10.1007/s00277-018-3308-7. Epub 2018 Mar 25.

Authors

Reinhard Marks¹, Monika Engelhardt¹, Sven Hager², Hannah Füllgraf³, Norbert P Südkamp², Georg W Herget⁴

Affiliations

¹ Department of Hematology, Oncology and Stem-Cell Transplantation, Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.
² Department of Orthopaedics and Trauma Surgery, Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
³ Department of Pathology, Medical Center Freiburg, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.
⁴ Department of Orthopaedics and Trauma Surgery, Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany. [email protected].

PMID: 29574568
DOI: 10.1007/s00277-018-3308-7

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Bone Neoplasms* / diagnostic imaging
Bone Neoplasms* / secondary
Bone Neoplasms* / therapy
Chemoradiotherapy*
Cyclophosphamide / administration & dosage
Doxorubicin / administration & dosage
Humans
Lymphoma, Large B-Cell, Diffuse* / drug therapy
Lymphoma, Large B-Cell, Diffuse* / therapy
Male
Methotrexate / administration & dosage
Middle Aged
Prednisone / administration & dosage
Rituximab / administration & dosage
Sarcoidosis, Pulmonary / diagnostic imaging
Sarcoidosis, Pulmonary / therapy
Tibia / diagnostic imaging*
Vincristine / administration & dosage

Substances

Rituximab
Vincristine
Doxorubicin
Cyclophosphamide
Prednisone
Methotrexate